MedKoo Cat#: 573426 | Name: Adaprolol maleate
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Adaprolol maleate is a beta-blocker and opthalmic which may be used in the treatment of Glaucoma or other ailments of the eye. Adaprolol has marked electrophysiologic effects. Its major action was on sinus node; it prolonged the basic sinus cycle length and had significant effect on intrinsic automaticity as reflected by the prolonged corrected sinus node recovery time and sinuatrial conduction time. There was, also, direct effect on atrial function and AV nodal function. Adaprolol prolonged the effective refractory period of the His-Purkinje system and the ventricle. The potency of adaprolol's electrophysiologic effects are higher compared to other widely used beta-blockers. Adaprolol appears to be a potent beta-blocker with particularly strong antiarrhythmic effect and it would be very useful in the treatment of both supraventricular and ventricular tachyarrhythmias and ectopic beats.

Chemical Structure

Adaprolol maleate
Adaprolol maleate
CAS#121009-31-2 (maleate)

Theoretical Analysis

MedKoo Cat#: 573426

Name: Adaprolol maleate

CAS#: 121009-31-2 (maleate)

Chemical Formula: C30H43NO8

Exact Mass:

Molecular Weight: 545.67

Elemental Analysis: C, 66.03; H, 7.94; N, 2.57; O, 23.46

Price and Availability

Size Price Availability Quantity
1mg USD 150.00 Ready to Ship
5mg USD 450.00 Ready to Ship
10mg USD 750.00 Ready to Ship
25mg USD 1,250.00 Ready to Ship
50mg USD 1,950.00 Ready to Ship
100mg USD 3,250.00 Ready to Ship
Show More
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
Synonym
Adaprolol maleate; CDDD 2803; CDDD-2803; CDDD2803; HGP 2; HGP-2; HGP2;
IUPAC/Chemical Name
Benzeneacetic acid, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, 2-tricyclo(3.3.1.1(sup 3,7))dec-1-ylethyl ester, (+-)-, (Z)-2-butenedioate (1:1) (salt)
InChi Key
WEBILLRFBZTUIX-BTJKTKAUSA-N
InChi Code
InChI=1S/C26H39NO4.C4H4O4/c1-18(2)27-16-23(28)17-31-24-5-3-19(4-6-24)12-25(29)30-8-7-26-13-20-9-21(14-26)11-22(10-20)15-26;5-3(6)1-2-4(7)8/h3-6,18,20-23,27-28H,7-17H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-
SMILES Code
O=C(OCCC1(C2)CC3CC2CC(C3)C1)CC4=CC=C(OCC(O)CNC(C)C)C=C4.O=C(O)/C=C\C(O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Biological target:
Adaprolol maleate is a beta-blocker and opthalmic which may be used in the treatment of Glaucoma or other ailments of the eye.
In vitro activity:
TBD
In vivo activity:
The present studies demonstrate that the potent ocular hypotensive effects of adaprolol are not stereoselective. In contrast, cardiac effects could be detected after intravenous S(+) adaprolol, but not R(-) adaprolol. The studies confirm that adaprolol functions as a potent beta-adrenergic antagonist. The negligible systemic beta-blocking activity detected with opthalmic administration of adaprolol is consistent with soft drug design. Reference: J Ocul Pharmacol Ther. 1996 Summer;12(2):115-22. https://pubmed.ncbi.nlm.nih.gov/8773927/

Preparing Stock Solutions

The following data is based on the product molecular weight 545.67 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Boder N, Elkoussi A, Zuobi K, Kovacs P. Synthesis and pharmacological activity of adaprolol enantiomers: a new soft drug for treating glaucoma. J Ocul Pharmacol Ther. 1996 Summer;12(2):115-22. doi: 10.1089/jop.1996.12.115. PMID: 8773927. 2. Polgar P, Bodor N. Cardiac electrophysiologic effects of adaprolol maleate, a new beta-blocker, in closed chest dogs. Life Sci. 1991;48(16):1519-28. doi: 10.1016/0024-3205(91)90276-h. PMID: 1673212.
In vitro protocol:
TBD
In vivo protocol:
1. Boder N, Elkoussi A, Zuobi K, Kovacs P. Synthesis and pharmacological activity of adaprolol enantiomers: a new soft drug for treating glaucoma. J Ocul Pharmacol Ther. 1996 Summer;12(2):115-22. doi: 10.1089/jop.1996.12.115. PMID: 8773927. 2. Polgar P, Bodor N. Cardiac electrophysiologic effects of adaprolol maleate, a new beta-blocker, in closed chest dogs. Life Sci. 1991;48(16):1519-28. doi: 10.1016/0024-3205(91)90276-h. PMID: 1673212.
1: Bodor N, Buchwald P. Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems. AAPS J. 2005 Dec 7;7(4):E820-33. Review. PubMed PMID: 16594634; PubMed Central PMCID: PMC2750951. 2: Boder N, Elkoussi A, Zuobi K, Kovacs P. Synthesis and pharmacological activity of adaprolol enantiomers: a new soft drug for treating glaucoma. J Ocul Pharmacol Ther. 1996 Summer;12(2):115-22. PubMed PMID: 8773927. 3: Polgar P, Bodor N. Cardiac electrophysiologic effects of adaprolol maleate, a new beta-blocker, in closed chest dogs. Life Sci. 1991;48(16):1519-28. PubMed PMID: 1673212.